Gemphire Therapeutics

US-based, clinical-stage biopharma developing small molecule therapeutics for cardio-metabolic diseases

placeLivonia, Michigan, United States calendar_todayFounded 2011 groups5 employees language gemphire.com

Registered entities

Innovation

13 patent families (5 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 541 times.

YearFilings
20153
20163
20176
20189
20197
20205
20211
20221
20232

Investor mix

8 investors on record.

Investor typeCountShare
Venture capital788%
Angel & family office113%
Coming soon